Document and Entity Information
Document and Entity Information | Apr. 10, 2023 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0000105319 |
Document Type | 8-K/A |
Document Period End Date | Apr. 10, 2023 |
Entity Registrant Name | WW INTERNATIONAL, INC. |
Entity Incorporation State Country Code | VA |
Entity File Number | 001-16769 |
Entity Tax Identification Number | 11-6040273 |
Entity Address, Address Line One | 675 Avenue of the Americas |
Entity Address, Address Line Two | 6th Floor |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10010 |
City Area Code | (212) |
Local Phone Number | 589-2700 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, no par value |
Trading Symbol | WW |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | This Amendment No. 1 to Current Report on Form 8-K (“Amendment No. 1”) is being filed with the U.S. Securities and Exchange Commission (the “SEC”) solely to amend and supplement Item 9.01 of the Current Report on Form 8-K (the “Original Form 8-K”) filed by WW International, Inc. (the “Company”) on April 14, 2023, which reported under Item 2.01 the completion of the Company’s previously announced acquisition Weekend Health, Inc., doing business as Sequence (“Weekend Health”), among other events. Under Item 9.01 of the Original Form 8-K, the Company stated that (i) the financial statements and (ii) the pro forma financial information required to be provided under Item 9.01 of Form 8-K would be provided by amendment to the Original 8-K not later than 71 days after the date the Original 8-K was required to be filed. This Amendment No. 1 provides such information required by Item 9.01. |